![Torsten Fahrig](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Torsten Fahrig
Directeur Financier/CFO chez RESprotect GmbH
Profil
Torsten Fahrig has worked in various financial and operational roles for RESprotect GmbH and UroTiss GmbH.
He is currently the Chief Operating & Financial Officer at RESprotect GmbH and the Chief Financial Officer at UroTiss GmbH.
Postes actifs de Torsten Fahrig
Sociétés | Poste | Début |
---|---|---|
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | Directeur Financier/CFO | - |
UroTiss GmbH
![]() UroTiss GmbH Medical/Nursing ServicesHealth Services UroTiss Gmbh researches, develops, and manufactures pharmaceuticals for the treatment of urethral strictures and hypospadias. The company was founded by Dr. Gouya Ram-Liebig in 2005 and is headquartered in Dortmund, Germany. | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | Health Technology |
UroTiss GmbH
![]() UroTiss GmbH Medical/Nursing ServicesHealth Services UroTiss Gmbh researches, develops, and manufactures pharmaceuticals for the treatment of urethral strictures and hypospadias. The company was founded by Dr. Gouya Ram-Liebig in 2005 and is headquartered in Dortmund, Germany. | Health Services |